BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33962488)

  • 1. A fatal case of acute hemolytic transfusion reaction caused by anti-Wr
    Espinosa A; Garvik LJ; Trung Nguyen N; Jacobsen B
    Immunohematology; 2021 Mar; 37(1):20-24. PubMed ID: 33962488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hemolytic transfusion reaction caused by anti-Yt
    Raos M; Thornton N; Lukic M; Golubic Cepulic B
    Immunohematology; 2021 Mar; 37(1):13-17. PubMed ID: 33962487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
    Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
    Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overt immediate hemolytic transfusion reaction attributable to anti-Wr(a).
    Boctor FN
    Immunohematology; 2008; 24(3):113-5. PubMed ID: 19845079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemolytic reaction by anti-Wra: Case report and review of the hemovigilance database of a tertiary care hospital.
    Solves P; Tur S; Gómez-Seguí I; Viel M; Eiris J; Planells Y; Rodríguez R; Peñalver I; Castro E; de la Rubia J
    Transfus Apher Sci; 2022 Jun; 61(3):103342. PubMed ID: 34969586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal Acute Hemolytic Transfusion Reaction due to Anti-Wr
    Bahri T; de Bruyn K; Leys R; Weerkamp F
    Transfus Med Hemother; 2018 Nov; 45(6):438-441. PubMed ID: 30574061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hemolytic transfusion reaction associated with anti-Mt
    Claes V; Peyrard T; Deleers M; El Kenz H
    Transfusion; 2019 Nov; 59(11):3314-3318. PubMed ID: 31503331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R; Hendrickson JE
    Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and delayed hemolytic transfusion reactions secondary to HLA alloimmunization.
    Benson K; Agosti SJ; Latoni-Benedetti GE; Leparc GF
    Transfusion; 2003 Jun; 43(6):753-7. PubMed ID: 12757526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2.
    Lemay AS; Tong TN; Branch DR; Huang M; Sumner C; Oldfield L; Hawes J; Cserti-Gazdewich CM; Lau W
    Transfusion; 2018 Nov; 58(11):2506-2512. PubMed ID: 30299537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients.
    Strupp A; Cash K; Uehlinger J
    Transfusion; 1998; 38(11-12):1022-5. PubMed ID: 9838931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemolytic transfusion reaction due to anti-Le(b).
    Irani MS; Figueroa D; Savage G
    Transfusion; 2015 Oct; 55(10):2486-8. PubMed ID: 26018602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hemolytic transfusion reaction due to anti-Js(a) in an alloimmunized patient with a sickle cell syndrome.
    Anderson RR; Sosler SD; Kovach J; DeChristopher PJ
    Am J Clin Pathol; 1997 Dec; 108(6):658-61. PubMed ID: 9384447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-N and anti-Do
    Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
    Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
    Takeuchi C; Ohto H; Miura S; Yasuda H; Ono S; Ogata T
    Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.
    Irani MS; Karafin MS; Ernster L
    J Clin Apher; 2017 Feb; 32(1):59-61. PubMed ID: 27112240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Japanese multi-institutional collaborative study of antigen-positive red blood cell (RBC) transfusions in patients with corresponding RBC antibodies.
    Yamada C; Takeshita A; Ohto H; Ishimaru K; Kawabata K; Nomaguchi Y; Haraguchi Y; Abe M; Sobue K; Takenouchi H; Takadate J; Kamimura M; Katai A; Kasai D; Minami Y; Sugimoto T; Michino J; Nagai K; Kumagai M; Hasegawa Y; Ishizuka K; Ohtomo N; Yamada N; Muroi K; Matsushita T; Takahashi K
    Vox Sang; 2020 Jul; 115(5):456-465. PubMed ID: 32124460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model.
    Stowell SR; Henry KL; Smith NH; Hudson KE; Halverson GR; Park JC; Bennett AM; Girard-Pierce KR; Arthur CM; Bunting ST; Zimring JC; Hendrickson JE
    Blood; 2013 Aug; 122(8):1494-504. PubMed ID: 23801629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should pre-transfusion screening RBC panels contain Wr(a+) cells?
    Coluzzi S; De Nicolò MC; Quattrocchi L; Neri A; Ferruzzi I; Girelli G
    Transfus Med; 2010 Oct; 20(5):337-40. PubMed ID: 20409071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.